HeartBeam’s core VECG technology gathers 3D signals of the heart, transforming them into a 12-lead ECG. It encompasses both apparatuses and methodologies designed to facilitate the comparison of cardiac signals over time, specifically for the automated or assisted detection of heart attacks. This patent is the second patent related to the company’s watch concept. The company now has a total of 14 granted and allowed US patents.